Browse the latest research summaries in the field of regenerative medicine for spinal cord injury patients and caregivers.
Showing 1,271-1,280 of 2,298 results
Advanced Science, 2023 • October 23, 2023
This study investigates the use of hypoxic preconditioning to improve the therapeutic function of MSC-derived sEVs for treating IVD degeneration and chronic lower back pain. HP-sEVs were found to alle...
KEY FINDING: Hypoxic preconditioning enhances the therapeutic function of MSC-derived sEVs for IVD regeneration.
Journal of Neuroinflammation, 2023 • October 10, 2023
This study reveals two novel normally occurring CD47-dependent mechanisms that impede myelin debris clearance by acting as a cell surface receptor. First, CD47 on Schwann cells inhibits myelin disrupt...
KEY FINDING: Myelin debris clearance, axon regeneration, and function recovery were all faster in CD47−/− mice than in wild type mice.
Journal of Inflammation Research, 2023 • October 20, 2023
Mesenchymal stem cell (MSC) transplantation has demonstrated effectiveness in treating SCI through various preclinical and clinical studies. MSC transplantation provides nerve protection via anti-infl...
KEY FINDING: MSCs transplantation protects nerves through anti-inflammatory, anti-oxidant, anti-apoptotic, and increased blood flow mechanisms.
Nature Communications, 2023 • November 8, 2023
This study investigates the differences in ECM composition after CNS injury between species with high (zebrafish) and low (mammals) regenerative capacities. SLRPs are identified as inhibitory ECM fact...
KEY FINDING: SLRPs, including chondroadherin, fibromodulin, lumican, and prolargin, are enriched in rodent and human CNS lesions but not in zebrafish.
Cells, 2023 • October 20, 2023
This review focuses on improving the efficiency of direct pro-neural reprogramming as a potential aid for neuroregeneration in spinal cord injury (SCI). It overviews recent literature on reprogrammed ...
KEY FINDING: The review highlights novel targets for improving direct pro-neural reprogramming, including mitochondria, nucleoli, and G-quadruplexes.
Systematic Reviews, 2023 • November 10, 2023
This systematic review investigates the efficacy of stem cell sheet implantation for neuronal regeneration after spinal cord injury (SCI) in pre-clinical studies. The review finds that stem cell sheet...
KEY FINDING: Stem cell sheets improve motor and sensory function recovery in SCI animal models compared to untreated rats.
Bioactive Materials, 2024 • January 1, 2024
This study introduces an innovative approach to treating spinal cord injury (SCI) by transplanting engineered mitochondrial compounds that target macrophages. The engineered Mito-Tpp-CAQK compound enh...
KEY FINDING: Engineered mitochondrial compounds (Mito-Tpp-CAQK) significantly enhanced macrophage phagocytosis of myelin debris both in vitro and in vivo.
bioRxiv, 2024 • September 14, 2024
This study identifies the aryl hydrocarbon receptor (AhR) as a negative regulator of axon regeneration in DRG neurons following injury. Activation of AhR promotes stress response and inflammation at t...
KEY FINDING: AhR activation in DRG neurons inhibits axon regeneration after nerve injury.
Not specified, 2023 • October 31, 2023
The study identifies novel populations of bone marrow-derived myeloid cells with neuroprotective and pro-regenerative properties, generated through short-term culture with IL-4 and G-CSF. These IL-4/G...
KEY FINDING: IL-4/G-CSF polarization reprograms bone marrow neutrophils (BMNs), causing them to upregulate alternative activation markers and produce cytoprotective and growth factors, akin to zymosan-modulated counterparts.
World Journal of Stem Cells, 2023 • October 26, 2023
This article reviews the potential applications of dental pulp stem cells (DPSCs) and their derivatives in the field of nerve regeneration. This paper describes the current status of stem cell therapi...
KEY FINDING: DPSCs have significant potential in neural tissue engineering due to easy isolation, multidifferentiation potential, low immunogenicity, and low transplant rejection rate.